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A molecular model is proposed for the transmembrane channels formed by alamethicin and related 
polypeptides. The channels consist of an aggregate of rod-like helical polypeptides with a central aqueous 
core of ordered water. The helix dipole moment is considered to be the major factor modulating channel 
size, selectivity and field-dependent transitions. 
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1. INTRODUCTION 
A number of polypeptides have been 
demonstrated to affect the permeability properties 
of membranes by forming channels through them. 
Sequences of a family of such peptides [l-61, rich 
in a-aminoisobutyric acid (Aib) are shown in fig. 1. 
Structural investigations of natural [7-101 and 
synthetic [11,12] antibiotics, fragments and model 
peptides [ 1 1,131 have demonstrated that the chan- 
nel formers are largely helical, with 310 and a- 
helical structures being suggested. 
Structure-activity correlations have demonstrated 
that the polar nature of the C-terminus is not 
essential for membrane activity [11,13,14]. In fact, 
a 13-residue N-terminal fragment of alamethicin 
has been shown to be active in ion transport [15] 
and uncoupling oxidative phosphorylation in 
mitochondria [ 161. Hence, channel-forming activi- 
ty lies in the helical segment of the peptides. Here, 
we present a model for peptide transmembrane 
channels as a working hypothesis. 
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2. AMPHIPATHIC HELICES AND 
AGGREGATION 
Inspection of the sequences of the antibiotics 
reveals that they can form amphipathic helices; 
i.e., helices wherein the polar residues are largely 
clustered on one face leaving the others apolar 
[17,18]. This is illustrated for an a-helical arrange- 
ment of zervamicin in fig.2A. Aggregation of such 
helices can expose either polar faces suitable for 
aqueous phase aggregates stabilized by 
hydrophobic interactions, or apolar faces for 
membrane phase aggregation (see fig.3) by rota- 
tion around the axes of individual helices. Such 
lipid phase aggregates have been suggested for 
delta lysin [ 181, suzukacillin [ 191 and the 7 helices 
of bacteriorhodopsin [20]. 
The helical structures taken up by these peptides 
are too narrow to allow the passage of ions 
through the interior of individual helices [21]. 
Hence, channel formation requires the aggregation 
of peptide helices, forming an interstitial channel 
(fig. 3). Experimental support for this conclusion 
comes from the high power dependence (6th or 
9th) of conductance on peptide concentration 
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Fig.1. Sequences of some Aib containing antibiotics. 
Channel formation in planar membranes has been 
studied for alamethicin, suzukacillin, trichotoxin and 
zervamicin while hypelcin uncouples oxidative 
phosphorylation. 
[22,23]. Further, aggregation has been observed in 
aqueous [9,24-261 and organic [ 19,27,28] solvents. 
If the conducting channel is an aggregate it follows 
that its lifetime will depend critically on the 
monomer-monomer interactions that stabilize the 
aggregate in the membrane phase. These include 
interchain hydrogen bonding and dipole-dipole 
interactions. 
Analysis of the sequences reveals that the shorter 
antibiotics have residues (Thr, Hyp) with side 
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Fig.2. (A) Zervamicin IIA in an a-helical arrangement 
viewed down the helix axis. Note the segregation of the 
residues into non polar, weakly polar and polar faces. 
(B) Excess charge distribution in a peptide unit showing 
the resultant dipole moment (from [30]). (C) Schematic 
representation of the near-parallel orientations of 
peptide dipoles in a helix. 
chains capable of hydrogen bonding while a Gln 
residue is conserved in all the peptides. This 
residue has been shown to stabilize aggregates of 
suzukacillin fragments in CHCl3 [19], and a crystal 
structure of alamethicin [lo] indicates that it is in- 
volved in intermolecular hydrogen bonding, link- 
ing 2 of the 3 peptide molecules in the asymmetric 
unit. Lack of this residue drastically reduces 
lifetime of pores, which form none-the-less [29]. 
Thus, hydrogen bonding by sidechain NH or OH 
of one helix to backbone or sidechain carbonyls of 
an adjacent helix is likely to stabilize membrane 
aggregates and consequently lengthen channel 
lifetimes. 
3. HELIX MACRO-DIPOLES 
The other major stabilizing force is 
dipole-dipole interaction between peptide helices. 
Fig.2B shows the permanent dipole of the peptide 
unit and its near-parallel arrangement in helices to 
generate a large net dipole moment amounting to 
3.5 D per 1.5 A of an a-helix [30,31]. The dipole 
moment of the alamethicin monomer has been 
reported to be 40-80 D, depending on the condi- 
tions of measurement [27,28], that for the ag- 
gregate in dioxane being anomalously low [27] in- 
dicative of antiparallel orientations of the consti- 
tuent helices. Energies of interaction between helix 
dipoles have been estimated following the method 
in [31], assuming a dipole moment of 65 D after 
[32]. The difference in energies between the D and 
E states shown in fig.3 is -60 kcal.(mol aggre- 
gate)-’ in the absence of an electric field. Hence 
the aqueous phase aggregate is likely to be a 
‘minimum dipole’ aggregate. However, fields of 
the order of lo5 V.cm-’ in the membrane could 
populate high dipole states. 
A probable sequence of events is shown in fig.3: 
aqueous phase aggregation exposing the polar 
faces of the helices; insertion into membranes with 
concomitant rotation about helix axes to present a 
hydrophobic exterior and facilitate intermolecular 
hydrogen bonding forming a ‘closed pore’; voltage 
induced ejection of the ‘core piece’ in the ag- 
gregates (which is not hydrogen-bonded to its 
neighbours) thereby creating an open channel. The 
voltage dependence of alamethicin conductance 
has been ascribed to an increase in the number of 
open channels with increasing voltage [33,34]. The 
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Fig.3. Schematic representation of the aggregation of 
peptide helices viewed in cross-section. + and - refer to 
opposite orientations of the helix dipole. Bar indicates 
the polar face of the helix (see fig.2A) and represents 
side chains capable of hydrogen bond formation. (A) 
Aqueous phase aggregate with polar face exposed to 
solvent; ‘core piece’ is hatched. (B) Membrane phase 
aggregate. Note rotation of helices to allow interchain 
hydrogen bonding and exposure of the apolar face. The 
‘core piece’ is not hydrogen bonded and can be ejected 
by an applied potential to generate an open channel (C). 
@-I) Schematic representation of pore state transitions. 
Equilibria shown do not represent actual pathways. 
field experienced by an ion in the channel would be 
a resultant of the applied electric field, membrane 
surface charge effects and the field due to the helix 
dipoles. Hence, variations in the dipole states of 
the channels as depicted in fig.3 would be observed 
as variations in the conductance of the channel. 
Changes in the number of monomers making up a 
channel (fig.3) would also have this effect and 
could explain the observation that different con- 
ductance states of alamethicin have different chan- 
nel diameters as estimated by a sieving technique 
I351. 
The ion selectivity of these channels may be 
modulated by alterations in the aggregate size and 
dipole state which, in turn, alter the structures of 
the aqueous matrix. Such a channel should 
transport protons efficiently, as in ice [36]. Their 
high efficiency as uncouplers of oxidative 
phosphorylation [ 16,371 support this contention. 
Earlier models for the channel-forming activity 
of these peptides postulated that an applied voltage 
was obligatory for the insertion of the peptides in- 
to a membrane [34,38]. The dipole moment, when 
considered, was implicated in this step [34]. It has 
since been shown that no applied potential is re- 
quired for the insertion of alarnethicin into lipid 
membranes [39,40]. A more detailed model based 
on a crystal structure of alamethicin has been pro- 
posed, which postulates aggregates with Gln(7) 
sidechains protruding into the lumen [lo]. The 
dipole moment of the sidechain and the applied 
potential determine the orientation of the Gln car- 
boxamide group, which in turn modulates conduc- 
tivity. This model ascribes an important role to the 
Gln sidechain in interacting with hydrated cations 
and attempts to build up a hydrophilic channel in- 
terior. It may be noted that the packing of 
molecules in the crystal does not provide any sup- 
port for such an arrangement. The model also does 
not attempt to rationalize considerable 
structure-activity data, indicating that GIn(7) is 
not essential for the formation of voltage sensitive 
channels [42]. The crystal structure [lo], however, 
confirms that the peptides take up helical struc- 
tures and also detects intermolecular hydrogen 
bonding mediated by Gln(7), in support of this 
hypothesis. During preparation of this manuscript, 
the importance of helix dipoles in modulating 
membrane channel functions has also been 
recognized [43]. The model proposed here differs 
significantly in detail from [43], in that transmem- 
brane ‘flip-flop’ is not necessary for imparting 
voltage sensitivity. Furthermore, helix am- 
phipathicity and its influence on aggregation 
modes are explicitly considered here. 
4. CONCLUSION 
The model proposed is intended to stimulate fur- 
ther experimental approaches to the study of 
molecular mechanisms involved in the ionophoric 
activity of these channel formers. The model 
ascribes a largely structural role for the cylindrical 
peptide aggregate in providing a scaffolding for 
supporting large aqueous columms, which serve to 
enhance the ion permeabilities of lipid bilayers. 
The pores are postulated to be stabilized by 
dipole-dipole interactions and inter-chain 
hydrogen bonding and thus amenable to ex- 
perimental verification. Deamidation of the cen- 
tral Gln should lead to significantly shorter 
lifetimes due to loss of hydrogen bond forming 
ability and charge repulsion; substitution with an 
apolar residue should have a less pronounced ef- 
fect though both analogs should retain channel 
forming activity. The precise sequence of residues 
is not expected to be critical as long as the peptide 
is long enough (15-20 residues); constrained to 
adopt amphipathic a- of 310 helical conformations; 
and is capable of forming intermolecular hydrogen 
bonds deep within the bilayer so as to stabilize the 
channel aggregate. 
Preliminary studies indicate that analogs of 
suzukacillin fragments with Ala substituted for the 
central Gln are capable of forming transmembrane 
channels (unpublished). Reports of the activity of 
other channel analogs [13,29] and some s ~ t h e t i c  
polypeptides 129,413 are consistent with these 
predictions. 
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